Skip to main content
OpenTrials

Clinical trial condition

Major Depressive Disorder (MDD)

Explore clinical trials studying Major Depressive Disorder (MDD). Study availability and eligibility vary by location and protocol.

166 public trials 63 recruiting studies
Refine in advanced search Browse all conditions

Major Depressive Disorder (MDD) trial results

Recruiting

A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression

NCT07610473

Conditions
Behavior, Behavioral Symptoms, Depression, +5 more
Locations
  • Draig Clinical Site Phoenix, Arizona, United States
  • Draig Clinical Site Little Rock, Arkansas, United States
  • Draig Clinical Site Lafayette, California, United States
  • Draig Clinical Site Hialeah, Florida, United States
View all 17 locations
View Trial Details
Recruiting

ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response

NCT07284667

Conditions
Depressive Disorder, Depressive Disorder, Major, Depressive Disorder, Treatment-Resistant, +3 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Inland Psychiatric Medical Group Chino, California, United States
  • Behavioral Research Specialists, LLC Glendale, California, United States
  • Kadima Neuropsychiatry Institute La Jolla, California, United States
View all 23 locations
View Trial Details
Recruiting

Inhaled DMT for Major Depressive Disorder

NCT07562191

Conditions
Behavior, Behavioral Symptoms, Depressive Disorder, +9 more
Locations
  • Hospital de Saúde Mental Professor Frota Pinto Fortaleza, Ceará, Brazil
  • Complexo Hospitalar Universitário Professor Edgard Santos, Federal University of Bahia (HUPES-UFBA) Salvador, Estado de Bahia, Brazil
  • Instituto de Psiquiatria da Universidade Federal do Rio de Janeiro (IPUB-UFRJ) Rio de Janeiro, Brazil
  • Hospital Universitário Onofre Lopes - HUOL - UFRN Natal, Rio Grande do Norte, Brazil
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

NCT07065240

Conditions
Anxiety Disorders, Behavior, Behavioral Symptoms, +7 more
Locations
  • Seaport Investigator Site Chino, California, United States
  • Seaport Investigator Site Garden Grove, California, United States
  • Seaport Investigator Site Glendale, California, United States
  • Seaport Investigator Site Redlands, California, United States
View all 61 locations
View Trial Details
Recruiting

Predictors of Relapse in Major Depressive Disorder (PERFORM-D)

NCT06746155

Conditions
Depressive Disorder, Depressive Disorder, Major, Disease Attributes, +6 more
Locations
  • University of Calgary Calgary, Alberta, Canada
  • University of British Columbia Vancouver, British Columbia, Canada
  • Nova Scotia Health Halifax, Nova Scotia, Canada
  • McMaster University Hamilton, Ontario, Canada
View Trial Details

Related conditions